News
Professor Nathan Gianneschi will receive the $10,000 Kabiller Young Investigator’s Award in Nanoscience and Nanomedicine for ...
23h
News-Medical.Net on MSNEstrogen-responsive cells found to heighten gut pain in femalesResearchers uncovered how estrogen heightens gut sensitivity in females by activating PYY-secreting L-cells, which stimulate ...
Northwestern University's International Institute for Nanotechnology (IIN) has announced the recipients of the 2025 ...
13h
News-Medical.Net on MSNCould a diabetes drug be the key to stopping Alzheimer’s?Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...
Alzinova AB (Nasdaq First North: ALZ) today announces a strategic collaboration with Worldwide Clinical Trials ("Worldwide"), a global leader in neuroscience studies, appointing them as the Clinical R ...
Chronic low back pain (CLBP) is a widespread and long-lasting condition defined by lower back pain that lasts for at least 12 weeks. The l ...
Northwestern University’s International Institute for Nanotechnology (IIN) has announced the recipients of the 2025 ...
The dissolving microneedle market has gained significant traction in recent years as an innovative approach to drug delivery ...
Bone growth occurs through the proliferation of specialized cells of the cartilage tissue, known as chondrocytes, on either end of a bone. This process requires the synthesis of extracellular matrix ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
Expanded alliance combines Lisata's drug development expertise with GATC's AI-powered Multiomics Advanced Technology® platform to accelerate and improve success rates of next-generation drug developme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results